• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider De Brunner Aidan

    5/25/23 4:05:29 PM ET
    $BBLN
    Medical/Nursing Services
    Health Care
    Get the next $BBLN alert in real time by email
    SEC FORM 3 SEC Form 3
    FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0104
    Estimated average burden
    hours per response: 0.5
    1. Name and Address of Reporting Person*
    de Brunner Aidan

    (Last) (First) (Middle)
    1 KNIGHTSBRIDGE GREEN

    (Street)
    LONDON X0 SW1X 7QA

    (City) (State) (Zip)
    2. Date of Event Requiring Statement (Month/Day/Year)
    05/19/2023
    3. Issuer Name and Ticker or Trading Symbol
    Babylon Holdings Ltd [ BBLN ]
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    Remarks:
    Exhibit No. 24.1 Power of Attorney dated May 6, 2023.
    No securities are beneficially owned.
    Aidan de Brunner 05/25/2023
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $BBLN alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $BBLN

    DatePrice TargetRatingAnalyst
    3/16/2023Buy → Neutral
    BTIG Research
    1/5/2023$4.00 → $20.00Buy
    BTIG Research
    6/23/2022$2.00Neutral
    BofA Securities
    4/28/2022$5.50Hold
    Berenberg
    1/12/2022$9.00Buy
    Deutsche Bank
    12/7/2021$8.00Neutral
    Citigroup
    12/2/2021$14.00Buy
    Canaccord Genuity
    12/2/2021$9.00Hold
    Jefferies
    More analyst ratings

    $BBLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Babylon downgraded by BTIG Research

      BTIG Research downgraded Babylon from Buy to Neutral

      3/16/23 7:14:08 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • BTIG Research reiterated coverage on Babylon with a new price target

      BTIG Research reiterated coverage of Babylon with a rating of Buy and set a new price target of $20.00 from $4.00 previously

      1/5/23 9:37:21 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • BofA Securities initiated coverage on Babylon with a new price target

      BofA Securities initiated coverage of Babylon with a rating of Neutral and set a new price target of $2.00

      6/23/22 9:05:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    SEC Filings

    See more
    • Babylon Holdings Limited filed SEC Form 8-K: Other Events

      8-K - Babylon Holdings Ltd (0001866390) (Filer)

      8/31/23 5:18:08 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Holdings Limited filed SEC Form 8-K: Other Events

      8-K - Babylon Holdings Ltd (0001866390) (Filer)

      8/11/23 5:01:17 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form NT 10-Q filed by Babylon Holdings Limited

      NT 10-Q - Babylon Holdings Ltd (0001866390) (Filer)

      8/10/23 5:21:19 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Vnv Global Ab (Publ)

      4 - Babylon Holdings Ltd (0001866390) (Issuer)

      6/30/23 4:18:26 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form 4 filed by Vnv Global Ab (Publ)

      4 - Babylon Holdings Ltd (0001866390) (Issuer)

      6/28/23 5:29:39 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form 4 filed by Vnv (Cyprus) Ltd

      4 - Babylon Holdings Ltd (0001866390) (Issuer)

      6/26/23 6:25:34 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Babylon Proceeds With Previously Announced Transaction and Announces the Receipt of Continued Listing Standards Notice from NYSE and Upcoming Delisting

      Babylon Holdings Limited (the "Company" or "Babylon") (NYSE:BBLN) previously announced in its June 23, 2023 press release that the Company has received a proposal from AlbaCore Capital LLP ("AlbaCore") and MindMaze Group SA ("MindMaze") pursuant to which core operating subsidiaries of the Company would be transferred to MindMaze (the "Proposed Transaction"). The closing of the Proposed Transaction is expected in July 2023 and is subject to agreed documentation, various conditions and appropriate approvals, if required. The Proposed Transaction will not provide for any payment to the Company's Class A ordinary shareholders or other equity instrument holders, as AlbaCore will be exercising ri

      6/28/23 4:30:00 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Announces Update on Take Private Proposal

      After a thorough exploration of strategic alternatives, Babylon Holdings Limited (NYSE:BBLN) (including its subsidiaries, "Babylon") is pleased to provide an update on the recapitalization transaction, previously announced on May 10, following receipt of a proposal from AlbaCore Capital LLP on behalf of certain of its affiliates ("AlbaCore") and MindMaze Group SA ("MindMaze"), and share that Babylon has selected the previously announced take private proposal from the options considered. The proposal strongly positions Babylon to accelerate its core mission – to make high quality healthcare more accessible and affordable by combining the most cutting-edge technology with the best medical ex

      6/23/23 6:00:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Reports Q1 2023 Financial Results

      Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial and operating results for the first quarter ended March 31, 2023. First Quarter Financial Results Comparison of the following financial results for the three months ended March 31, 2023, to the three months ended March 31, 2022: Total revenue was $311.1 million compared to $266.4 million, a 1.2x year-over-year increase of $44.7 million. This was primarily due to the growth in VBC revenue, which increased by 17% year-over-year to $287.5 million in Q1 2023. Net loss totaled $63.2 million, a (20.3)% Net loss margin compared to Net loss of $29.1 million, a (10.9)% Net loss margin in Q1 2022

      5/10/23 6:01:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Babylon Holdings Limited (Amendment)

      SC 13D/A - Babylon Holdings Ltd (0001866390) (Subject)

      6/29/23 5:26:01 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Babylon Holdings Limited (Amendment)

      SC 13G/A - Babylon Holdings Ltd (0001866390) (Subject)

      2/14/23 11:54:33 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Babylon Holdings Limited (Amendment)

      SC 13G/A - Babylon Holdings Ltd (0001866390) (Subject)

      11/14/22 4:08:50 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Leadership Updates

    Live Leadership Updates

    See more
    • Babylon Appoints David Humphreys as Chief Financial Officer

      Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company"), one of the world's fastest growing digital healthcare companies, announces that David Humphreys will be appointed as the Company's new Chief Financial Officer. Mr. Humphreys has been at Babylon for nearly two years in the role of Finance Director, with overall responsibility for building and scaling Babylon's finance function. Formerly, he was US-based as a Silicon Valley and New York Partner with PwC for over 20 years, working with Boards and leaders of fast-moving, rapid-growth companies including Tesla and Facebook to which he provided accounting consulting, transaction, IPO, M&A and auditing services to ensure complianc

      8/23/22 5:10:00 PM ET
      $BBLN
      Medical/Nursing Services
      Health Care

    $BBLN
    Financials

    Live finance-specific insights

    See more
    • Babylon Reports Q1 2023 Financial Results

      Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial and operating results for the first quarter ended March 31, 2023. First Quarter Financial Results Comparison of the following financial results for the three months ended March 31, 2023, to the three months ended March 31, 2022: Total revenue was $311.1 million compared to $266.4 million, a 1.2x year-over-year increase of $44.7 million. This was primarily due to the growth in VBC revenue, which increased by 17% year-over-year to $287.5 million in Q1 2023. Net loss totaled $63.2 million, a (20.3)% Net loss margin compared to Net loss of $29.1 million, a (10.9)% Net loss margin in Q1 2022

      5/10/23 6:01:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Announces First Quarter 2023 Earnings Conference Call

      Babylon (NYSE:BBLN) (the "Company") today announced it will host a conference call to review its first quarter financial results on Wednesday, May 10, 2023, at 8:00 AM Eastern Time. A press release announcing the results will be issued prior to the conference call on Wednesday, May 10, 2023. To participate in the live conference call and webcast, please dial (877) 407-7994 for U.S. participants, 0 800 756 3429 for U.K. participants or +1 215-268-9868 for international participants. Alternatively, you can visit the "News & Events" section of https://ir.babylonhealth.com to access the live webcast. On this page, you can also find a "Call me" link for instant telephone access to the event, w

      4/19/23 6:00:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care
    • Babylon Reports Another Strong Year Exceeding Guidance, and Accelerates Expected Adjusted EBITDA Profitability to Mid-2024

      Revenue grew 3.5x YoY, to $1.11 billion, exceeding guidance Cost of Care Delivery (COCD) Margin in the U.K. already profitable1, with U.S. Clinical services also expecting COCD profitability in early 2023 Key U.S. VBC contracts delivered profitable Medical Margins2 in their first year Monthly Adjusted EBITDA of $(16.3) million for Q4 2022 beating guidance of $(18) million Adjusted EBITDA profitability expected in mid-2024, significantly earlier than previous guidance Commercial VBC revenue substantially increased with recent launch of Ambetter digital-first service across 6 states Babylon Holdings Limited (NYSE:BBLN) ("Babylon" or the "Company") today announced its financial an

      3/9/23 6:00:00 AM ET
      $BBLN
      Medical/Nursing Services
      Health Care